NCT05802927已完成不适用
A Randomized Controlled Trial to Determine the Effects of Diabetes-specific Formula on Glycemic Control in Individuals With Type 2 Diabetes
适应症
干预措施
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 64
- 试验地点
- 2
- 主要终点
- Postprandial blood glucose
研究概览
简要总结
A randomized, controlled, crossover design with three treatments to determine the effects of diabetes-specific formula on glycemic control in individuals with type 2 diabetes.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Crossover
- 主要目的
- Treatment
- 盲法
- Single (Outcomes Assessor)
入排标准
- 年龄范围
- 21 Years 至 65 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Participants are eligible to be included in the study only if all of the following criteria apply:
- •Has type 2 diabetes as evidenced by use of oral antihyperglycemic medication(s).
- •BMI > 18.5 and ≤ 35.0 kg/m
- •Weight stable.
- •Male or non-pregnant, non-lactating female, at least 6 weeks postpartum prior to screening visit.
- •If on chronic medication, the dosage to be constant for at least two months prior to screening visit and to maintain the medication and dose throughout the study.
- •Willing to follow the protocol throughout the study.
- •At least a two-week washout period between completion of a previous research study and their start in the current study.
- •Willing to refrain from taking non-study diabetes-specific formulas over the course of the study.
- •Voluntarily signed and dated an Informed Consent Form (ICF) prior to any participation in the study.
排除标准
- •Participants are excluded from the study if any of the following criteria apply:
- •Has a screening HbA1c level < 7% or ≥ 10%.
- •Uses exogenous insulin for glucose control.
- •Has confirmed type 1 diabetes and/or had history of diabetic ketoacidosis.
- •Has current infection, inpatient surgery or received systemic corticosteroid treatment in the last 3 months; or received antibiotics in the last 3 weeks.
- •Has active malignancy.
- •Has significant cardiovascular event within 6 months prior to study entry or history of congestive heart failure.
- •Has end stage organ failure or was post organ transplant.
- •Has a history of renal disease or severe gastroparesis.
- •Has current hepatic disease.
- •Has had bariatric surgery including gastric balloon; history of gastrointestinal disease or intestinal surgery that can interfere with consumption or digestion or absorption of study product.
- •Has a chronic, contagious, infectious disease.
- •Has eating disorder, severe dementia or delirium, history of significant neurological or psychiatric disorder, alcoholism, substance abuse or other conditions that may interfere with study product consumption or compliance with study protocol procedures.
- •Taking any herbals, dietary supplements or medications other than allowed anti-hyperglycemic medications, during the past four weeks prior to screening visit that could profoundly affect blood glucose or appetite.
- •Uses diabetes-specific formula(s) defined as more than one eating occasion per week in the last three months.
- •Has clotting or bleeding disorders.
- •Participates in another study that has not been approved as a concomitant study by Abbott Nutrition.
- •Has allergy or intolerance to any ingredient in the study product.
研究组 & 干预措施
Experimental: Breakfast 2 Glutinous rice
Other
干预措施: Breakfast 2 (Other)
Experimental: Diabetes-specific formula
Other
干预措施: DSF (Other)
Experimental: Breakfast 1 Noodle Soup
Other
干预措施: Breakfast 1 (Other)
结局指标
主要结局
Postprandial blood glucose
时间窗: 3 hours
Positive area under the curve (AUC) for blood glucose concentration from 0 to 180 minutes.
次要结局
- Postprandial insulin(3 hours)
- Appetite(3 hours)
研究者
研究点 (2)
Loading locations...
相似试验
尚未招募
不适用
Evaluating the Effect of Adipose Tissue Processed With the SyntrFuge™ System in the Healing of Diabetic Foot UlcersDiabetic Foot UlcerNCT05519501Syntr Health Technologies, Inc.62
已完成
不适用
Diabetes-Specific Formula in Individuals With Type 2 DiabetesDiabetes Mellitus, Type 2NCT04303754Abbott Nutrition100
已完成
不适用
Evaluation of Glycemic Response in Individuals With Type 2 DiabetesGlycemic ControlNCT05165693Abbott Nutrition24
已完成
不适用
Glycemic Response to Three Oral Nutrition Supplements in Persons With Type 2 Diabetes MellitusDiabetesNCT02856516Société des Produits Nestlé (SPN)12
已完成
不适用
To Assess the Efficacy of Investigational Product on the Neuropathic Pain in Individuals Suffering From Type II Diabetes Mellitus.Diabetic NeuropathiesInsomnia Due to Medical ConditionNCT04504305Vedic Lifesciences Pvt. Ltd.64